Robeco Institutional Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Hold
11,721
﹤0.01% 787
2026
Q1
$388K Buy
+11,721
New +$496K ﹤0.01% 803
2025
Q3
Sell
-10,237
Closed -$303K 868
2025
Q2
$303K Hold
10,237
﹤0.01% 829
2025
Q1
$306K Hold
10,237
﹤0.01% 866
2024
Q4
$293K Sell
10,237
-104,728
-91% -$3.47M ﹤0.01% 864
2024
Q3
$4.44M Buy
114,965
+83,548
+266% +$2.98M 0.01% 571
2024
Q2
$1.01M Buy
+31,417
New +$1.09M ﹤0.01% 769
2023
Q2
Sell
-9,503
Closed -$228K 1058
2023
Q1
$228K Buy
+9,503
New +$252K ﹤0.01% 930

Other funds holding COLL

Robeco Institutional Asset Management's COLL Position: Q2 2026 in Review

Robeco Institutional Asset Management held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 11,721 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Robeco Institutional Asset Management first reported a position in COLL in Q1 2023 and has held it in 8 quarters since. The position peaked at $4.44M in Q3 2024. 101 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Robeco Institutional Asset Management held 11,721 shares of Collegium Pharmaceutical worth $424K as of Q2 2026.
  • Robeco Institutional Asset Management left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #787 holding.
  • Robeco Institutional Asset Management first reported a position in Collegium Pharmaceutical in Q1 2023 and has held it in 8 quarters since.
  • Robeco Institutional Asset Management's Collegium Pharmaceutical position peaked at $4.44M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.